In this episode of Executive Insights for Life Sciences Innovators, we speak with Mark Stead of Atomic AI, a biotech harnessing artificial intelligence and structural biology to unlock RNA’s therapeutic potential. Mark shares how Atomic AI is building a discovery platform to model RNA structures with unprecedented accuracy, opening the door to new classes of medicines for oncology, rare diseases, and beyond.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on August 22, 2025.

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Larry Tiffany, CEO of GenrAb, to explore how the company is developing fully human neuroprotective antibodies to address neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. Larry discusses GenrAb’s scientific approach, the promise of neuroprotection in slowing disease progression, and the challenges of advancing novel biologics in today’s biotech landscape.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on June 20, 2025.

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Saurabh Johri, Chief Business Officer at Catena Biosciences, a pioneering company revolutionizing protein conjugation technologies for next-generation therapeutics. Saurabh shares insights on Catena’s platform, its potential to reshape therapeutic development, and the company’s vision for advancing precision medicine through novel protein engineering approaches.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on June 6, 2025.

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Darren Dasburg, CEO of Clarus Biologics, a company advancing vaccine and immunology innovation through a novel adjuvant platform designed to improve immune responses, particularly in vulnerable populations. Darren shares insights on Clarus Biologics’ technology, its potential applications in global health, and the company’s strategy for bringing novel adjuvant solutions to market.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on May 19, 2025.

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Ayla Annac, CEO and Co-Founder of InvivoSciences, a precision medicine company transforming the way therapies are discovered and developed for heart failure and cardiometabolic diseases. Ayla shares insights into InvivoSciences’ innovative platform, the promise of patient-specific models in drug discovery, and the company’s vision for advancing precision medicine.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on April 11, 2025.

In this episode of Executive Insights for Life Sciences Innovators, we speak with Anna Kazanchyan, MD, CEO of Saghmos Therapeutics, about the company’s mission to revolutionize cardiovascular and kidney protection. We explore how their lead drug candidate, ST-62516, is designed to prevent Major Adverse Cardiac and Kidney Events (MACKE) in high-risk patients undergoing PCI. Dr. Kazanchyan discusses the science behind ST-62516, why it has a strong likelihood of FDA approval, and the company’s strategic approach to clinical trials, regulatory success, and market exclusivity.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on March 28, 2025.

In this episode of Executive Insights for Life Sciences Innovators, we speak with Charles Swindell, CEO of Glycotest, about the company’s proprietary technology that measures glycoprotein fucosylation for the detection of liver diseases. Charles shares insights on the science behind Glycotest’s platform, the challenges of bringing diagnostic innovation to market, and the future of precision liver disease detection.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on March 14, 2025.

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Rich Shea, CEO of Basking Biosciences, to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care.

Learn more at genecoda.com.

Originally recorded and streamed on YouTube Live on February 24, 2025.